job News Investors Health professionals Patients Providers Contact TO TO TO IS About Lilly CSR Medicines R&D Lilly Europe Your Health it starts with a PROMISE Our commitment to improving life goes beyond the drugs we make. It is at the heart of our activity Present September 19, 2017 # 1deCada20mil makes visible the reality of patients with soft tissue sarcoma, a complex and unknown cancer September 14, 2017 EADV Congress: New data from an international survey reveals that people with psoriasis expected more from their treatments September 13, 2017 “Come on, Team Coco!”, The new story by Lilly and Disney to normalize diabetes among the little ones terms and conditions of use data privacy policy copyright cookies policy site map Copyright © 2017 Eli Lilly and Company. All rights reserved Last Updated: 09/19/17 06:34:54

job News Investors Health professionals Patients Providers Contact TO TO TO IS About Lilly CSR Medicines R&D Lilly Europe Your Health INFORMATION FOR PATIENTS We know that both your health and that of your loved ones is the most important thing. That's why at Lilly we strive to keep patients at the center of everything we do. We work from medical needs that, to this day, have not yet been resolved. That is why each new drug becomes a great success that arises out of 100,000 failed attempts and, our best reward, the success stories of the patients themselves who have already received some of our treatments. Osteoporosis Oncology Diabetes RHEUMATOID ARTHRITIS DIABETES NEUROSCIENCES ONCOLOGY OSTEOPOROSIS PSORIASIS CLINICAL RESEARCH MEN'S HEALTH NEUROSCIENCES terms and conditions of use data privacy policy copyright cookies policy site map Copyright © 2017 Eli Lilly and Company. All rights reserved Last Updated: 05/09/17 07:12:00

job News Investors Health professionals Patients Providers Contact TO TO TO IS About Lilly CSR Medicines R&D Lilly Europe Your Health ONCOLOGY Lilly has also contributed her grain of sand to the history of oncology and the fight against this disease or group of diseases. In the 60s, thanks to the study of the properties of vinca alkaloids, he introduced oncolytics that have contributed to fighting this pathology and since then his effort has not stopped. In addition to this research effort, Lilly intends to support the work of professionals and institutions to face all the needs that accompany people who, in their family environment, have to fight against this evil. What should we know Gastric cancer RHEUMATOID ARTHRITIS DIABETES NEUROSCIENCES ONCOLOGY What should we know Stomach cancer OSTEOPOROSIS PSORIASIS CLINICAL RESEARCH MEN'S HEALTH NEUROSCIENCES terms and conditions of use data privacy policy copyright cookies policy site map Copyright © 2017 Eli Lilly and Company. All rights reserved Last Updated: 04/09/17 08:46:31